CAMP-response-element-binding protein positively regulates breast cancer metastasis and subsequent bone destruction

Biochemical and Biophysical Research Communications

Volumn 398, Issue 2, 2010, Pages 309-314

  Son, Jieun ^a   Lee, Jong Ho ^a   Kim, Ha Neui ^a   Ha, Hyunil ^a   Lee, Zang Hee ^a  

^a Seoul National University   (South Korea)

Author keywords

Bone metastasis; Breast cancer; CREB; PTHrP; TGF

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN K; INTERLEUKIN 1; MATRIX METALLOPROTEINASE; OSTEOPROTEGERIN; PARATHYROID HORMONE RELATED PROTEIN; SOMATOMEDIN C; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DESTRUCTION; BONE LESION; BREAST CANCER; BREAST METASTASIS; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; OSTEOLYSIS; PRIORITY JOURNAL; RISK FACTOR; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; WILD TYPE;

ANIMALS; BONE NEOPLASMS; BREAST NEOPLASMS; CELL LINE, TUMOR; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-17; MATRIX METALLOPROTEINASES; MICE; MICE, NUDE; NEOPLASM METASTASIS; OSTEOLYSIS; OSTEOPROTEGERIN; PARATHYROID HORMONE-RELATED PROTEIN; TRANSFORMING GROWTH FACTOR BETA; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 77955052998     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.06.087     Document Type: Article

References (27)

1. Nguyen D.X., Bos P.D., Massague J. Metastasis: from dissemination to organ-specific colonization. Nat. Rev. Cancer 2009, 9:274-284.
2. Yin J.J., Selander K., Chirgwin J.M., Dallas M., Grubbs B.G., Wieser R., Massague J., Mundy G.R., Guise T.A. TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J. Clin. Invest. 1999, 103:197-206.
3. Mayr B., Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat. Rev. Mol. Cell. Biol. 2001, 2:599-609.
4. Rudolph D., Tafuri A., Gass P., Hammerling G.J., Arnold B., Schutz G. Impaired fetal T cell development and perinatal lethality in mice lacking the cAMP response element binding protein. Proc. Natl. Acad. Sci. USA 1998, 95:4481-4486.
5. Arany Z., Sellers W.R., Livingston D.M., Eckner R. E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators. Cell 1994, 77:799-800.
6. Sakamoto K.M., Frank D.A. CREB in the pathophysiology of cancer: implications for targeting transcription factors for cancer therapy. Clin. Cancer Res. 2009, 15:2583-2587.
7. Shankar D.B., Cheng J.C., Kinjo K., Federman N., Moore T.B., Gill A., Rao N.P., Landaw E.M., Sakamoto K.M. The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia. Cancer Cell 2005, 7:351-362.
8. Crans-Vargas H.N., Landaw E.M., Bhatia S., Sandusky G., Moore T.B., Sakamoto K.M. Expression of cyclic adenosine monophosphate response-element binding protein in acute leukemia. Blood 2002, 99:2617-2619.
9. Xie S., Price J.E., Luca M., Jean D., Ronai Z., Bar-Eli M. Dominant-negative CREB inhibits tumor growth and metastasis of human melanoma cells. Oncogene 1997, 15:2069-2075.
10. Seo H.S., Liu D.D., Bekele B.N., Kim M.K., Pisters K., Lippman S.M., Wistuba I.I., Koo J.S. Cyclic AMP response element-binding protein overexpression: a feature associated with negative prognosis in never smokers with non-small cell lung cancer. Cancer Res. 2008, 68:6065-6073.
11. Aggarwal S., Kim S.W., Ryu S.H., Chung W.C., Koo J.S. Growth suppression of lung cancer cells by targeting cyclic AMP response element-binding protein. Cancer Res. 2008, 68:981-988.
12. Chhabra A., Fernando H., Watkins G., Mansel R.E., Jiang W.G. Expression of transcription factor CREB1 in human breast cancer and its correlation with prognosis. Oncol. Rep. 2007, 18:953-958.
13. Cha-Molstad H., Keller D.M., Yochum G.S., Impey S., Goodman R.H. Cell-type-specific binding of the transcription factor CREB to the cAMP-response element. Proc. Natl. Acad. Sci. USA 2004, 101:13572-13577.
14. Lee J.H., Kim H.N., Yang D., Jung K., Kim H.M., Kim H.H., Ha H., Lee Z.H. Trolox prevents osteoclastogenesis by suppressing RANKL expression and signaling. J. Biol. Chem. 2009, 284:13725-13734.
15. Voronov E., Shouval D.S., Krelin Y., Cagnano E., Benharroch D., Iwakura Y., Dinarello C.A., Apte R.N. IL-1 is required for tumor invasiveness and angiogenesis. Proc. Natl. Acad. Sci. USA 2003, 100:2645-2650.
16. Dunn S.E., Ehrlich M., Sharp N.J., Reiss K., Solomon G., Hawkins R., Baserga R., Barrett J.C. A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer. Cancer Res. 1998, 58:3353-3361.
17. Walton K.M., Rehfuss R.P., Chrivia J.C., Lochner J.E., Goodman R.H. A dominant repressor of cyclic adenosine 3',5'-monophosphate (cAMP)-regulated enhancer-binding protein activity inhibits the cAMP-mediated induction of the somatostatin promoter in vivo. Mol. Endocrinol. 1992, 6:647-655.
18. John A., Tuszynski G. The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol. Oncol. Res. 2001, 7:14-23.
19. Hamzaoui H., Rizk-Rabin M., Gordon J., Offutt C., Bertherat J., Bouizar Z. PTHrP P3 promoter activity in breast cancer cell lines: role of Ets1 and CBP (CREB binding protein). Mol. Cell. Endocrinol. 2007, 268:75-84.
20. Wu D., Zhau H.E., Huang W.C., Iqbal S., Habib F.K., Sartor O., Cvitanovic L., Marshall F.F., Xu Z., Chung L.W. CAMP-responsive element-binding protein regulates vascular endothelial growth factor expression: implication in human prostate cancer bone metastasis. Oncogene 2007, 26:5070-5077.
21. Park J.K., Park S.H., So K., Bae I.H., Yoo Y.D., Um H.D. ICAM-3 enhances the migratory and invasive potential of human non-small cell lung cancer cells by inducing MMP-2 and MMP-9 via Akt and CREB. Int. J. Oncol. 2010, 36:181-192.
22. Massague J. TGFbeta in cancer. Cell 2008, 134:215-230.
23. Pigazzi M., Manara E., Baron E., Basso G. MiR-34b targets cyclic AMP-responsive element binding protein in acute myeloid leukemia. Cancer Res. 2009, 69:2471-2478.
24. Qin H., Sun Y., Benveniste E.N. The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. J. Biol. Chem. 1999, 274:29130-29137.
25. Muller A., Homey B., Soto H., Ge N., Catron D., Buchanan M.E., McClanahan T., Murphy E., Yuan W., Wagner S.N., Barrera J.L., Mohar A., Verastegui E., Zlotnik A. Involvement of chemokine receptors in breast cancer metastasis. Nature 2001, 410:50-56.
26. Jones D.H., Nakashima T., Sanchez O.H., Kozieradzki I., Komarova S.V., Sarosi I., Morony S., Rubin E., Sarao R., Hojilla C.V., Komnenovic V., Kong Y.Y., Schreiber M., Dixon S.J., Sims S.M., Khokha R., Wada T., Penninger J.M. Regulation of cancer cell migration and bone metastasis by RANKL. Nature 2006, 440:692-696.
27. Fata J.E., Kong Y.Y., Li J., Sasaki T., Irie-Sasaki J., Moorehead R.A., Elliott R., Scully S., Voura E.B., Lacey D.L., Boyle W.J., Khokha R., Penninger J.M. The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development. Cell 2000, 103:41-50.